☆ 4.6 Editorial Material

We Can Finally Stop Worrying About SGLT2 Inhibitors and Acute Kidney Injury

AMERICAN JOURNAL OF KIDNEY DISEASES (2020)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF KIDNEY DISEASES
Volume 76, Issue 4, Pages 454-456

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2020.05.014

Keywords

-

Categories

Urology & Nephrology

Funding

  1. Janssen
  2. Boehringer Ingelheim
  3. Eli Lilly Co
  4. Sanofi
  5. AstraZeneca
  6. Merck Co Inc.

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.